Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality worldwide. Despite advances in treatment, the prognosis remains poor, highlighting the need for novel therapeutic strategies. The present review explores the potential of targeted epidermal growth factor receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Crintea, Andreea, Constantin, Anne-Marie, Motofelea, Alexandru C., Crivii, Carmen-Bianca, Velescu, Maria A., Coșeriu, Răzvan L., Ilyés, Tamás, Crăciun, Alexandra M., Silaghi, Ciprian N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532491/
https://www.ncbi.nlm.nih.gov/pubmed/37754880
http://dx.doi.org/10.3390/jfb14090466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532491/
https://www.ncbi.nlm.nih.gov/pubmed/37754880
http://dx.doi.org/10.3390/jfb14090466

Ejemplares similares